Specify a stock or a cryptocurrency in the search bar to get a summary
Boule Diagnostics AB
BOULBoule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden. Address: Domnarvsgatan 4, Spånga, Sweden, 163 53
Analytics
WallStreet Target Price
955.64 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BOUL
Dividend Analytics BOUL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
56 %Dividend History BOUL
Stock Valuation BOUL
Financials BOUL
Results | 2019 | Dynamics |